Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes
- PMID: 14715656
- DOI: 10.1074/jbc.M313041200
Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes
Abstract
Osteoarthritis is characterized by the loss of aggrecan and collagen from the cartilage extracellular matrix. The proteinases responsible for the breakdown of cartilage aggrecan include ADAMTS-4 (aggrecanase 1) and ADAMTS-5 (aggrecanase 2). Post-translational inhibition of ADAMTS-4/-5 activity may be important for maintaining normal homeostasis of aggrecan metabolism, and thus, any disruption to this inhibition could lead to accelerated aggrecan breakdown. To date TIMP-3 (tissue inhibitor of matrix metalloproteinases-3) is the only endogenous inhibitor of ADAMTS-4/-5 that has been identified. In the present studies we identify alpha(2)-macroglobulin (alpha(2)M) as an additional endogenous inhibitor of ADAMTS-4 and ADAMTS-5. alpha(2)M inhibited the activity of both ADAMTS-4 and ADAMTS-5 in a concentration-dependent manner, demonstrating 1:1 stoichiometry with second-order rate constants on the order of 10(6) and 10(5) m(-1) s(-1), respectively. Inhibition of the aggrecanases was mediated by proteolysis of the bait region within alpha(2)M, resulting in physical entrapment of these proteinases. Both ADAMTS-4 and ADAMTS-5 cleaved alpha(2)M at Met(690)/Gly(691), representing a novel proteinase cleavage site within alpha(2)M and a novel site of cleavage for ADAMTS-4 and ADAMTS-5. Finally, the use of the anti-neoepitope antibodies to detect aggrecanase-generated alpha(2)M-fragments in synovial fluid was investigated and found to be uninformative.
Similar articles
-
The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.J Biol Chem. 2000 Aug 18;275(33):25791-7. doi: 10.1074/jbc.M001065200. J Biol Chem. 2000. PMID: 10827174
-
Aggrecanase and aggrecan degradation in osteoarthritis: a review.J Int Med Res. 2008 Nov-Dec;36(6):1149-60. doi: 10.1177/147323000803600601. J Int Med Res. 2008. PMID: 19094423 Review.
-
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.J Biol Chem. 2002 Jun 21;277(25):22201-8. doi: 10.1074/jbc.M200431200. Epub 2002 Apr 15. J Biol Chem. 2002. PMID: 11956193
-
Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.J Biol Chem. 2004 Mar 12;279(11):10109-19. doi: 10.1074/jbc.M312123200. Epub 2003 Dec 8. J Biol Chem. 2004. PMID: 14662755
-
Aggrecanases and cartilage matrix degradation.Arthritis Res Ther. 2003;5(2):94-103. doi: 10.1186/ar630. Epub 2003 Feb 14. Arthritis Res Ther. 2003. PMID: 12718749 Free PMC article. Review.
Cited by
-
Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration.Front Cell Dev Biol. 2022 Mar 14;9:780749. doi: 10.3389/fcell.2021.780749. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35359916 Free PMC article. Review.
-
The role of ADAMTSs in arthritis.Protein Cell. 2010 Jan;1(1):33-47. doi: 10.1007/s13238-010-0002-5. Epub 2010 Feb 7. Protein Cell. 2010. PMID: 21203996 Free PMC article. Review.
-
Extracellular matrix turnover and outflow resistance.Exp Eye Res. 2009 Apr;88(4):676-82. doi: 10.1016/j.exer.2008.11.023. Epub 2008 Dec 6. Exp Eye Res. 2009. PMID: 19087875 Free PMC article. Review.
-
ADAMTS-5: A difficult teenager turning 20.Int J Exp Pathol. 2020 Feb;101(1-2):4-20. doi: 10.1111/iep.12344. Epub 2020 Mar 27. Int J Exp Pathol. 2020. PMID: 32219922 Free PMC article. Review.
-
Regulated proteolytic processing of Reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators.PLoS One. 2012;7(10):e47793. doi: 10.1371/journal.pone.0047793. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082219 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous